Refreshing results…
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Download from doi.orgGATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Download from doi.orgA Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
UploadMissing publications? Search for publications with a matching author name.